<DOC>
	<DOCNO>NCT00144560</DOCNO>
	<brief_summary>This open-label , clinical pharmacology study investigate drug-drug interaction patient RA .</brief_summary>
	<brief_title>Drug-Drug Interaction Study MRA Patient With Rheumatoid Arthritis ( RA )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Inclusion criterion Patients diagnose RA accord 1987 American College Rheumatology ( ACR ) classification criterion Patients contract RA least 6 month prior Exclusion criterion Patients Class IV Steinbrocker functional impairment enrollment . Patients treat underlying disease biological agent , infliximab etanercept receive treatment leflunomide , within 12 week initiation treatment probe drug</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2008</verification_date>
</DOC>